Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis

BACKGROUND: Newborn screening (NBS) for cystic fibrosis (CF) not only identifies infants with a diagnosis of CF, but also those with an uncertain diagnosis of cystic fibrosis (CF), i.e. CF transmembrane conductance regulator (CFTR)-related metabolic syndrome (CRMS) or CF screen positive inconclusive...

Descripción completa

Detalles Bibliográficos
Autores principales: Ooi, Chee Y., Sutherland, Rosie, Castellani, Carlo, Keenan, Katherine, Boland, Margaret, Reisman, Joe, Bjornson, Candice, Chilvers, Mark A., van Wylick, Richard, Kent, Steven, Price, April, Mateos-Corral, Dimas, Hughes, Daniel, Solomon, Melinda, Zuberbuhler, Peter, Brusky, Janna, Durie, Peter R., Ratjen, Felix, Gonska, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805545/
https://www.ncbi.nlm.nih.gov/pubmed/31640630
http://dx.doi.org/10.1186/s12887-019-1756-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805545/
https://www.ncbi.nlm.nih.gov/pubmed/31640630
http://dx.doi.org/10.1186/s12887-019-1756-4

Ejemplares similares